Hasan T, Medcalf E, Nyang'wa BT, Egizi E, Berry C, et al.
2024-03-20 • Clinical Infectious Diseases
2024-03-20 • Clinical Infectious Diseases
BACKGROUND Effectiveness, safety, tolerability, and adherence are critical considerations in shifting to shorter tuberculosis (TB) regimens. Novel 6-month oral regimens that include ...
Doltu S, Ciobanu A, Sereda Y, Persian R, Ravenscroft L, et al.
2021-09-29 • Journal of Infection in Developing Countries
2021-09-29 • Journal of Infection in Developing Countries
INTRODUCTION The Republic of Moldova is among the 18 high priority countries for tuberculosis (TB) in Europe. This study compared adherence and short and long-term TB treatment outco...
Dolgusev O, Obevzenco N, Padalco O, Pankrushev S, Ramsay AR, et al.
2014-10-21 • Public Health Action
2014-10-21 • Public Health Action
This cohort study assessed drug susceptibility testing (DST) patterns and associated treatment outcomes from Transnistria, Moldova, from 2009 to 2012. Of 1089 newly registered tuberculos...
Marshall C, Curtis A, Spelman T, O'Brien DP, Greig J, et al.
2013-07-23 • PLOS One
2013-07-23 • PLOS One
To identify associations between specific WHO stage 3 and 4 conditions diagnosed after ART initiation and all cause mortality for patients in resource-limited settings (RLS). DESIGN, SET...
Ciobanu A, Domente L, Soltan V, Bivol S, Severin L, et al.
2014-10-21 • Public Health Action
2014-10-21 • Public Health Action
SETTING Tuberculosis (TB) health facilities in the Republic of Moldova, where various incentives were provided to TB patients to improve treatment outcomes.
